| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $10.42M | - | |
| CFO | 158.7K | $7.14M | - | |
| VP | 111.5K | $5.02M | - | |
| COO | 27.9K | $1.26M | - | |
| Dir | 25.7K | $1.16M | -2,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2018 | Anstice David W | Director | Sale+OE | 8,787 | $35.59 | $312,710.24 | -4.2% | |
| Dec 3, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $36.45 | $36,450.00 | -100% | |
| Nov 2, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $37.51 | $37,510.00 | -100% | |
| Oct 1, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $42.42 | $42,420.00 | -100% | |
| Sep 4, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $44.58 | $44,580.00 | -100% | |
| Aug 1, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $43.68 | $43,680.00 | -100% | |
| Jul 16, 2018 | Bloom Floyd E | Director | Sell | 20,000 | $43.95 | $879,024.00 | -13.5% | |
| Jul 3, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $41.86 | $41,860.00 | -100% | |
| Jun 12, 2018 | Frates James M83 | SVP, Alks Inc; CFO Alks | Sell | 16,842 | $50.00 | $842,179.16 | -31.1% | |
| Jun 1, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $47.34 | $47,340.00 | -100% |